Publication:
Maraviroc contributes to the restoration of the homeostasis of regulatory T-cell subsets in antiretroviral-naive HIV-infected subjects.

No Thumbnail Available

Date

2016-01-22

Authors

Pozo-Balado, M M
Rosado-Sánchez, I
Méndez-Lagares, G
Rodríguez-Méndez, M M
Ruiz-Mateos, E
Benhnia, M R
Muñoz-Fernández, M A
Leal, M
Pacheco, Y M

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Regulatory T (Treg) cells comprise different functional subsets with different CCR5 expression. Treg homeostasis is disrupted by HIV but the effect of treatment has barely been explored. In a longitudinal design, we compared the effect of a maraviroc-containing (n = 9) or sparing (n = 12) therapy in antiretroviral-naive HIV-positive participants on peripheral FoxP3(low) CD45RA(+) (nTreg), FoxP3(high) CD45RA(-) (eTreg) and FoxP3(low) CD45RA(-) (non-Treg) cells. Maraviroc significantly reduced all subsets in the short-term and, except for nTreg cells, also normalized them in the long-term. The correlation between eTreg cells and CD4 counts, lost before treatment, was only restored by maraviroc. The differential effect of maraviroc on Treg subsets contributes to understanding its immunomodulatory effects.

Description

MeSH Terms

CCR5 Receptor Antagonists
CD4 Lymphocyte Count
Cyclohexanes
Forkhead Transcription Factors
HIV Infections
Homeostasis
Humans
Immunophenotyping
Leukocyte Common Antigens
Longitudinal Studies
Maraviroc
T-Lymphocyte Subsets
T-Lymphocytes, Regulatory
Triazoles

DeCS Terms

CIE Terms

Keywords

CCR5, HIV, Regulatory T-cells, effector-Treg, homeostasis, maraviroc, naive-Treg, non-Treg

Citation